Fat jabs ‘slash risk of killer illness’ affecting 2 million Brits – even if you DON’T lose weight

JABS like Wegovy slash the risk of a type of liver disease affecting 2 million Brits, even when people don't lose weight, scientists say. Semaglutide - the active ingredient in Wegovy and diabetes jab Ozempic - can improve liver function independent of weight loss, Canadian researchers showed. Metabolic dysfunction-associated steatotic liver disease (MASLD) is a...